New Analyst Forecast: $ACLX Given $133.0 Price Target - Quiver Quantitative
2 days ago • Google News
Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
2 days ago • Google News
4 days ago • Google News